Literature DB >> 3587642

Contrast visual testing in neurovisual diagnosis.

R W Lorance, D Kaufman, S H Wray, C Mao.   

Abstract

Contrast visual testing (CVT) is a psychophysical visual test of undetermined diagnostic capability in many neurovisual disorders. CVT of 32 controls and 39 patients was compared with the pattern visual evoked response (PVER) from each group. CVT was more sensitive than PVER in detecting visual dysfunction in pseudotumor cerebri and subclinical optic neuritis and showed potential in distinguishing papilledema from pseudopapilledema. PVER was more sensitive than CVT in detecting subclinical visual dysfunction in MS and optic nerve compression. Neither was abnormal in asymptomatic Leber's optic neuropathy. In nonorganic visual loss, CVT data were variable and inconsistent, supporting this diagnosis; PVER was consistently normal. Although in certain disease conditions, each detected subclinical visual dysfunction, neither CVT nor PVER provided specific information leading to an etiologic diagnosis.

Entities:  

Mesh:

Year:  1987        PMID: 3587642     DOI: 10.1212/wnl.37.6.923

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

Review 1.  The Biophysics of Visual Edge Detection: A Review of Basic Principles.

Authors:  Hassan Kesserwani
Journal:  Cureus       Date:  2020-10-28

2.  Contrast sensitivity function and pituitary adenoma: a study of 40 cases.

Authors:  M Grochowicki; A Vighetto; S Berquet; G Sassolas
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

3.  Primary face motor area as the motor representation of articulation.

Authors:  Yasuo Terao; Yoshikazu Ugawa; Tomotaka Yamamoto; Yasuhisa Sakurai; Tomohiko Masumoto; Osamu Abe; Yoshitaka Masutani; Shigeki Aoki; Shoji Tsuji
Journal:  J Neurol       Date:  2007-03-22       Impact factor: 4.849

4.  Neurophysiological and psychophysical measurements reveal effects of acute low-level organic solvent exposure in humans.

Authors:  L Altmann; A Böttger; H Wiegand
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.